NewAmsterdam Pharma (NAMS) Invested Capital (2022 - 2026)
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Invested Capital (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | NewAmsterdam Pharma | 3.13 Bn | 3.13 Bn | - | 685.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 685.87 Mn |
| Mar 31, 2026 | 715.45 Mn |
| Dec 31, 2025 | 740.70 Mn |
| Sep 30, 2025 | 772.43 Mn |
| Jun 30, 2025 | 799.43 Mn |
| Mar 31, 2025 | 800.89 Mn |
| Dec 31, 2024 | 795.01 Mn |
| Sep 30, 2024 | 397.76 Mn |
| Jun 30, 2024 | 410.98 Mn |
| Mar 31, 2024 | 444.86 Mn |
| Dec 31, 2023 | 300.97 Mn |
| Jun 30, 2023 | 468.23 Mn |
| Dec 31, 2022 | 498.30 Mn |